Form 4: Teradyne Director Marilyn Matz Executes Stock Sale

Teradyne Director Marilyn Matz sold 1,200 shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Director Marilyn Matz sold 1,200 shares of Teradyne, Inc. (TER) common stock.
• The transaction occurred on June 15, 2026, at a price of $423.03 per share.
• Following the sale, the director retains 17,440.675 shares of common stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted under a pre-established, automated trading plan.

Positives

• The transaction was pre-planned, indicating the sale was not based on non-public information regarding current company performance.

Negatives

• Insider selling can sometimes be perceived by the market as a lack of confidence in future share price appreciation, though this was a scheduled sale.

Risks

• Market volatility affecting the value of remaining holdings.

Future Outlook

No forward-looking guidance or operational outlook was provided in this filing.

Industry Context

StockSavvy.ai notes that routine insider selling via 10b5-1 plans is a standard practice for corporate directors to manage personal liquidity and is generally viewed as neutral by the market.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate insiders to avoid potential conflicts of interest or accusations of insider trading.

Stakeholder Impact

• Minimal impact on shareholders as the sale was pre-planned and represents a small portion of the director's total holdings.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Teradyne, TER, Insider Trading, Form 4, Stock Sale, Rule 10b5-1